Disulfide With Human Monoclonal CSL312 Lambda-chain

Disulfide With Human Monoclonal CSL312 Lambda-chain Uses, Dosage, Side Effects, Food Interaction and all others data.

Disulfide With Human Monoclonal CSL312 Lambda-chain is under investigation in clinical trial NCT04281524 (A Clinical Study to Test the Efficacy and Safety of CSL312 on Catheter-associated Blood Clot Formation in Subjects With Cancer Who Receive Chemotherapy Through a PICC Line).

Trade Name Disulfide With Human Monoclonal CSL312 Lambda-chain
Generic Garadacimab
Garadacimab Other Names Garadacimab, Immunoglobulin G4, anti-(human blood-coagulation factor viia) (human monoclonal CSL312 gamma4-chain), disulfide with human monoclonal CSL312 lambda-chain, dimer
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Disulfide With Human Monoclonal CSL312 Lambda-chain
Disulfide With Human Monoclonal CSL312 Lambda-chain

Innovators Monograph

You find simplified version here Disulfide With Human Monoclonal CSL312 Lambda-chain


*** Taking medicines without doctor's advice can cause long-term problems.
Share